Immunology Insurance Policy Changes

Intravenous Immune Globulin (IVIG) - Alyglo™ (Immune Globulin Intravenous (Human)-stwk) Asceniv™ (Immune Globulin Intravenous (Human) - slra); Bivigam®; Flebogamma® DIF; Gammagard® Liquid; Gammagard® Liquid ERC; Gammagard® S/D; Gammaked™; Gammaplex®; Gamunex®-C; Octagam®; Panzyga ® (Immune Globulin Intravenous (Human) - ifas); Privigen®; Qivigy® (Immune Globulin Intravenous (Human) - kthm); Yimmugo® (Immune Globulin Intravenous (Human) - dira)

New comprehensive policy for Intravenous Immune Globulin (IVIG) therapy covering 14 different IVIG products with detailed prior authorization requirements for both FDA-approved and compendial uses. The policy establishes specific coverage criteria and documentation requirements for various conditions including primary immunodeficiency, ITP, CIDP, and multiple other indications.